University of Colorado

Immunomolecular Therapeutics, Inc.

Steve Orndorff

Aaron Michels

Peter Gottlieb

Peter A Gottlieb

Compounds and compositions useful in methods of treating, ameliorating, or inhibiting the development of autoimmune diseases or Celiac disease by modulating the binding of DQ8 MHC class II molecules to antigenic peptides or fragments of antigenic peptides.

Compounds and methods for treating autoimmunity

Methods of administering methyldopa to a subject in a fasting state to increase bioavailability of the methyldopa.

Administration of oral methyldopa

Methods of treating, ameliorating, or inhibiting the development of autoimmune diseases by modulating the binding of MHC class II molecules to antigenic peptides or fragments of antigenic peptides of the autoimmune disease. The binding may be modulated by the administration of D-&#x3b1;-methyldopa, or pharmaceutical compositions comprising therapeutically effective amounts of D-&#x3b1;-methyldopa.

Growing community of inventors

Broomfield, CO, United States of America

Steve Orndorff